With respect and in reference to your previous post I think you may be missing the problem. The “professional” short case is a financial one. Not referring to the twitter crew. Going short is an opportunity to make money. Say If I saw an opportunity that I thought was overvalued and I thought the market was wrong In it’s valuation I would want my broker / fund manager to position accordingly - this being against the market trend. It’s not because I want to hurt people, destroy companies for pleasure, create pain and misery, it’s simply about making money. If I was paying my manager fees and they missed this opportunity I’d be pissed off. There is very little wriggle room for morals and ethics when the objective is to be a pirate within the confines of the law and make money. The overarching thematic is that “the market” will always price a company at what it’s worth at any given time. Right now us retail holders believe that the market valuation is wrong and we are undervalued yet the short case says no, it’s got more room to drop. The golden question is why. Has something changed fundamentally? Shareholders are always last to know and it’s naive to think otherwise as history has shown and will continue to show until the rule book changes.
Now with the DFS being pushed back, even for good reason, is where the twitter crew have their field day. It’s simply preying on uncertainty. It’s hard to discern between what is the twitter social media campaign effect and what is a genuine short case against the valuation of the company. In the mean time we are back to speculation and with that speculation comes the emotion.
The DFS would have been an end to this rubbish in my opinion but we just have to keep guessing as to what the company is worth in the time until it’s ready.
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-23718
-
- There are more pages in this discussion • 20,361 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.5¢ | $92.09K | 5.787M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 0.016 |
43 | 7873041 | 0.015 |
15 | 5136049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 2962774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online